Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 4
2006 5
2007 4
2008 3
2009 6
2010 9
2011 10
2012 14
2013 16
2014 13
2015 23
2016 25
2017 30
2018 46
2019 44
2020 46
2021 40
2022 55
2023 49
2024 47
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Pencik J, Philippe C, Schlederer M, Atas E, Pecoraro M, Grund-Gröschke S, Li WJ, Tracz A, Heidegger I, Lagger S, Trachtová K, Oberhuber M, Heitzer E, Aksoy O, Neubauer HA, Wingelhofer B, Orlova A, Witzeneder N, Dillinger T, Redl E, Greiner G, D'Andrea D, Östman JR, Tangermann S, Hermanova I, Schäfer G, Sternberg F, Pohl EE, Sternberg C, Varady A, Horvath J, Stoiber D, Malcolm TI, Turner SD, Parkes EE, Hantusch B, Egger G, Rose-John S, Poli V, Jain S, Armstrong CWD, Hoermann G, Goffin V, Aberger F, Moriggl R, Carracedo A, McKinney C, Kennedy RD, Klocker H, Speicher MR, Tang DG, Moazzami AA, Heery DM, Hacker M, Kenner L. Pencik J, et al. Among authors: hacker m. Mol Cancer. 2023 Aug 12;22(1):133. doi: 10.1186/s12943-023-01825-8. Mol Cancer. 2023. PMID: 37573301 Free PMC article.
PET in bladder cancer imaging.
Muin D, Laukhtina E, Hacker M, Shariat SF. Muin D, et al. Among authors: hacker m. Curr Opin Urol. 2023 May 1;33(3):206-210. doi: 10.1097/MOU.0000000000001090. Epub 2023 Mar 6. Curr Opin Urol. 2023. PMID: 36876730 Review.
Nuclear medicine innovations help (drive) healthcare (benefits).
Hacker M, Beyer T, Baum RP, Kalemis A, Lammertsma AA, Lewington V, Talbot JN, Verzijlbergen F. Hacker M, et al. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):173-5. doi: 10.1007/s00259-014-2957-6. Eur J Nucl Med Mol Imaging. 2015. PMID: 25416634 Free PMC article. No abstract available.
"Metabolic fingerprints" of cachexia in lung cancer patients.
Frille A, Arends J, Abenavoli EM, Duke SA, Ferrara D, Gruenert S, Hacker M, Hesse S, Hofmann L, Holm SH, Lund TB, Rullmann M, Sandøe P, Sciagrà R, Shiyam Sundar LK, Tönjes A, Wirtz H, Yu J, Sabri O, Beyer T; (the LuCaPET consortium). Frille A, et al. Among authors: hacker m. Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):2067-2069. doi: 10.1007/s00259-024-06689-8. Epub 2024 Mar 20. Eur J Nucl Med Mol Imaging. 2024. PMID: 38504039 Free PMC article. No abstract available.
A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study.
Ning J, Spielvogel CP, Haberl D, Trachtova K, Stoiber S, Rasul S, Bystry V, Wasinger G, Baltzer P, Gurnhofer E, Timelthaler G, Schlederer M, Papp L, Schachner H, Helbich T, Hartenbach M, Grubmüller B, Shariat SF, Hacker M, Haug A, Kenner L. Ning J, et al. Among authors: hacker m. Theranostics. 2024 Aug 1;14(12):4570-4581. doi: 10.7150/thno.96921. eCollection 2024. Theranostics. 2024. PMID: 39239512 Free PMC article.
Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism.
Ding J, Zhang Y, Wen J, Zhang H, Wang H, Luo Y, Pan Q, Zhu W, Wang X, Yao S, Kreissl MC, Hacker M, Tong A, Huo L, Li X. Ding J, et al. Among authors: hacker m. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2656-2665. doi: 10.1007/s00259-020-04722-0. Epub 2020 Mar 23. Eur J Nucl Med Mol Imaging. 2020. PMID: 32206838
Rudolf Höfer, MD, 1923-2023.
Hacker M, Beyer T. Hacker M, et al. J Nucl Med. 2024 Feb 1;65(2):335. doi: 10.2967/jnumed.123.267216. J Nucl Med. 2024. PMID: 38302160 Free article. No abstract available.
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Kornauth C, Pemovska T, Vladimer GI, Bayer G, Bergmann M, Eder S, Eichner R, Erl M, Esterbauer H, Exner R, Felsleitner-Hauer V, Forte M, Gaiger A, Geissler K, Greinix HT, Gstöttner W, Hacker M, Hartmann BL, Hauswirth AW, Heinemann T, Heintel D, Hoda MA, Hopfinger G, Jaeger U, Kazianka L, Kenner L, Kiesewetter B, Krall N, Krajnik G, Kubicek S, Le T, Lubowitzki S, Mayerhoefer ME, Menschel E, Merkel O, Miura K, Müllauer L, Neumeister P, Noesslinger T, Ocko K, Öhler L, Panny M, Pichler A, Porpaczy E, Prager GW, Raderer M, Ristl R, Ruckser R, Salamon J, Schiefer AI, Schmolke AS, Schwarzinger I, Selzer E, Sillaber C, Skrabs C, Sperr WR, Srndic I, Thalhammer R, Valent P, van der Kouwe E, Vanura K, Vogt S, Waldstein C, Wolf D, Zielinski CC, Zojer N, Simonitsch-Klupp I, Superti-Furga G, Snijder B, Staber PB. Kornauth C, et al. Among authors: hacker m. Cancer Discov. 2022 Feb;12(2):372-387. doi: 10.1158/2159-8290.CD-21-0538. Epub 2021 Oct 11. Cancer Discov. 2022. PMID: 34635570 Free PMC article.
437 results